NCT05464628View on ClinicalTrials.gov

Drug Interaction Study of ASC42 With Atorvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 8, 2022

Primary Completion Date

August 23, 2022

Study Completion Date

August 30, 2022

Conditions
Healthy
Interventions
DRUG

Atorvastatin

Atorvastatin followed by ASC42 daily followed by separate co-administration of atorvastatin

DRUG

ASC42

Atorvastatin followed by ASC42 daily followed by separate co-administration of atorvastatin

Trial Locations (1)

78209

ICON, San Antonio

Sponsors
All Listed Sponsors
lead

Gannex Pharma Co., Ltd.

INDUSTRY

NCT05464628 - Drug Interaction Study of ASC42 With Atorvastatin | Biotech Hunter | Biotech Hunter